Results 81 to 90 of about 1,789 (148)

Transitional care for a patient with chronic obstructive pulmonary disease [PDF]

open access: yes, 2016
2011-2012 > Academic research: refereed > Publication in refereed journalVersion of ...
Fu, SY, Wang, SL, Wong, KY, Zhou, JY
core  

中国10个地区成年男性Y染色体嵌合缺失流行病学分布及其与肺癌的前瞻性关联研究 [Epidemiological distribution of mosaic loss of chromosome Y in adult men in 10 areas in China and its prospective association with lung cancer] [PDF]

open access: yes
Objective To detect the prevalence of mosaic loss of chromosome Y in adult men in ten study areas in China, describe the epidemiological distribution of mosaic loss of chromosome Y (mLOY) carriers and assess its prospective association with lung cancer.
Chen, Junshi   +9 more
core   +2 more sources

慢性阻塞性肺疾病加重期和稳定期Th17和Treg细胞的表达

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2013
摘 要: 【目的】 探讨慢性阻塞性肺疾病( COPD) 急性加重期、稳定期患者和肺功能正常吸烟者外周血中Th17 、Treg细胞的表达。【方法】 选取慢性阻塞性肺疾病急性加重患者28例、慢性阻塞性肺疾病稳定期患者22例、吸烟肺功能正常者(对照组)22例为研究对象。流式细胞术检测外周血中Th17细胞、CD4+CD25high Treg细胞的比例,ELISA 检测诱导痰IL-17、TGF-β1的水平。【结果】 急性加重期COPD组的外周血Th17比例(%)较稳定期COPD组增高(2.92 ± 0.16 vs
doaj  

血清降钙素原和C-反应蛋白在慢性支气管炎急性发作期的检测意义分析

open access: yesZhongguo shiyan zhenduanxue, 2015
慢性支气管炎是常见慢性呼吸系统疾病,病情呈现慢性进展,可反复发作,在其病程中可并发阻塞性肺气肿、肺动脉高压等,此类患者在感染等诱发因素作用下可发生急性发作,导致临床症状在短时间内加重,严重影响到患者生存质量。C反应蛋白和血清降钙素原均在机体发生感染时水平升高[1-3]。本文选择我院慢性支气管炎急性发作患者,观察C反应蛋白和血清降钙素原在此类患者体内内的水平改变情况,并分析其临床检测意义。现报告如下。
周捷, 范克
doaj  

[Association between vitamin D level and blood eosinophil count in healthy population and patients with chronic obstructive pulmonary disease]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao, 2023
Wang M   +8 more
europepmc   +1 more source

NLR和PLR与慢性阻塞性肺疾病的相关性

open access: yesZhongguo shiyan zhenduanxue, 2018
目的探讨NLR(中性粒细胞/淋巴细胞的比值)和PLR(血小板/淋巴细胞的比值)检测与慢性阻塞性肺疾病的相关性,为临床诊治提供参考依据。方法随机选择2014年6月-2016年7月在本院确诊为慢性阻塞性肺疾病的患者作为研究对象并分为稳定期组(80例)和因感染导致的急性加重期组(160例),其中急性加重期组患者按照肺功能情况又分为轻度组和重度组各80例,选择同期在本院健康体检结果为正常的150例体检人员作为对照组,均测定血常规和感染相关指标C反应蛋白(CRP)、降钙素原(PCT),手工计算NLR和PLR ...
胡秀梅
doaj  

Efficacy of direct-acting antiviral agents combined regimens for hepatitis C virus with different genotypes in Dehong Prefecture, Yunnan Province from 2022 to 2024 [PDF]

open access: yes
ObjectiveTo investigate the therapeutic effects of direct-acting antiviral agents (DAAs) combined regimens for hepatitis C virus (HCV) patients in Dehong Prefecture, Yunnan Province from 2022 to 2024, to analyze the characteristics of treatment failure ...
CAO Yanfen   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy